HKDC1 and neoplasm: Given its tumor-selective expression profile—minimal in normal hepatocytes versus abundant in malignancies, targeting HKDC1, particularly its association with the mitochondria, could offer a promising therapeutic strategy with high molecular specificity16, 17.